Briskness Pharmaceutical Traders Profile
Key Indicators
- Authorised Capital ₹ 0.16 M
as on 17-12-2024
- Paid Up Capital ₹ 0.15 M
as on 17-12-2024
- Company Age 14 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
About Briskness Pharmaceutical Traders
The Corporate was formerly known as Brijwasi Pharmaceutical Traders Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.16 M and a paid-up capital of Rs 0.15 M, as per Ministry of Corporate Affairs (MCA) records.
Anuj Singh and Suresh Rajak serve as directors at the Company.
- CIN/LLPIN
U74999DL2010PTC308132
- Company No.
308132
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Oct 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Briskness Pharmaceutical Traders?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anuj Singh  | Director | 01-Mar-2019 | Current |
| Suresh Rajak | Director | 26-Apr-2015 | Current |
Financial Performance and Corporate Structure Insights of Briskness Pharmaceutical Traders.
Briskness Pharmaceutical Traders Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Briskness Pharmaceutical Traders?
In 2017, Briskness Pharmaceutical Traders had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bharati Financial Advisory Private LimitedActive 13 years 11 monthsAnuj Singh and Suresh Rajak are mutual person
- Genuine Agricultural Marketing Private LimitedActive 14 years 2 months
Suresh Rajak is a mutual person
- Joyous Engineering Works Advisors Private LimitedActive 13 years 11 months
Suresh Rajak is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Briskness Pharmaceutical Traders?
Unlock and access historical data on people associated with Briskness Pharmaceutical Traders, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Briskness Pharmaceutical Traders, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Briskness Pharmaceutical Traders's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
